SPERO THERAPEUTICS INC SPRO
ASignal's systematic analysis rates SPRO as Neutral.
Reflects the latest available analysis · analyzed Oct 30, 2026
The case on SPRO
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong free cash flow of $28.85M
- Low debt-to-equity ratio of 0.05x
- High current and quick ratios indicating strong liquidity
- Positive return on equity at 19.17%
- Gross margin above 50%, indicating pricing power
- Enterprise value to revenue of 0.34x suggests undervaluation
- Negative price momentum (-0.0536)
- MACD below signal line and negative histogram
- RSI near oversold but not yet oversold
- No Reddit mentions indicating low retail interest
- Limited news coverage from only two sources
- Forward P/E negative, indicating expected earnings decline
See the full verdict on SPRO
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes SPRO
Most investors never get a second opinion, let alone several. ASignal runs SPRO past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.